rs75099879
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_006996.3(SLC19A2):c.796G>A(p.Val266Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,613,658 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006996.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC19A2 | NM_006996.3 | c.796G>A | p.Val266Met | missense_variant | 2/6 | ENST00000236137.10 | NP_008927.1 | |
SLC19A2 | NM_001319667.1 | c.205-6980G>A | intron_variant | NP_001306596.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC19A2 | ENST00000236137.10 | c.796G>A | p.Val266Met | missense_variant | 2/6 | 1 | NM_006996.3 | ENSP00000236137.5 | ||
SLC19A2 | ENST00000367804.4 | c.205-6980G>A | intron_variant | 1 | ENSP00000356778.3 | |||||
SLC19A2 | ENST00000646596.1 | c.796G>A | p.Val266Met | missense_variant | 2/6 | ENSP00000494404.1 |
Frequencies
GnomAD3 genomes AF: 0.00689 AC: 1049AN: 152170Hom.: 12 Cov.: 32
GnomAD3 exomes AF: 0.00190 AC: 477AN: 250962Hom.: 6 AF XY: 0.00164 AC XY: 223AN XY: 135798
GnomAD4 exome AF: 0.000687 AC: 1004AN: 1461370Hom.: 8 Cov.: 34 AF XY: 0.000607 AC XY: 441AN XY: 727016
GnomAD4 genome AF: 0.00692 AC: 1054AN: 152288Hom.: 12 Cov.: 32 AF XY: 0.00714 AC XY: 532AN XY: 74472
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 21, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 25, 2021 | - - |
Thiamine-responsive megaloblastic anemia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Jan 02, 2018 | ACMG criteria: PP3 (2 predictors), BP4 (9 predictors), BS1 (2.51% in ExAC African population), BS2 (10 homozygotes in gnomAD), BP6 (GeneDx calls benign)=benign - |
Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at